Notice Number: NOT-HL-19-725

Key Dates
Release Date: November 06, 2019

Issued by
National Heart, Lung, and Blood Institute (NHLBI)

Purpose

The purpose of this Notice is to inform potential applicants that the National Heart, Lung, and Blood Institute (NHLBI) is participating, effective immediately, in RFA-HD-20-002, "Pediatric HIV/AIDS Cohort Study (PHACS): 2020 (P01 Clinical Trial Not Allowed).”

The following sections of RFA-HD-20-002 have been modified (shown in italics):

Components of Participating Organizations

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
National Cancer Institute (NCI)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute on Deafness and Other Communication Disorders (NIDCD)
National Institute of Dental and Craniofacial Research (NIDCR)
National Institute on Drug Abuse (NIDA)
National Institute of Mental Health (NIMH)
National Institute of Neurological Disorders and Stroke (NINDS)

National Heart, Lung, and Blood Institute (NHLBI)

Catalog of Federal Domestic Assistance (CFDA) Number(s)

93.865; 93.393; 93.273; 93.855; 93.279; 93.173; 93.121; 93.242; 93.853, 93.837, 93.838, 93.839, 93.840, 93.233

Section I. Funding Opportunity Description.

Section VII. Agency Contacts

Scientific/Research Contact(s)

Sean Altekruse, DVM, MPH, PhD
National Heart, Lung, Blood Institute (NHLBI)
Telephone: 301-435-1290
Email: [email protected]

Financial/Grants Management Contact(s)

Lynn Rundhaugen
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-480-4546
Email: [email protected]

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Sean Altekruse, DVM, MPH, PhD
National Heart, Lung, Blood Institute (NHLBI)
Telephone: 301-435-1290
Email: [email protected]